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ABSTRACT
We are analysing the initial molecular events stimu-
lated by the high-affinity receptor for IgE, Fce RI. Earlier
studies have shown that the first response when the
receptor-bound IgE interacts with a multivalent antigen
is a transphosphorylation of receptor tyrosines,
induced by the approximation of two or more recep-
tors by a constitutively associated src-family kinase
(Lyn). The amount of weakly associated kinase regu-
lates the intensity of the response. Several aspects are
being analyzed: (i) the sites on Lyn and the receptor
that account for the constitutive interaction; (ii) how the
intrinsic affinity of a ligand for the receptor-bound IgE
influences the responses; and (iii) the mechanism(s) by
which low-affinity ligands can act as antagonists. In
the latter studies, mast cell responses were followed by
monitoring the phosphorylation of tyrosines on several
proteins and secretion. At equivalent levels of receptor
phosphorylation, a ligand with high affinity stimulated
vigorous phosphorylation of downstream compo-
nents, whereas a low-affinity ligand was unable to
stimulate phosphorylation of the same components
effectively. Cells stimulated with a mixture of high- and
low-affinity ligands, under a protocol where simple
displacement of one by the other was prevented,
remarkably showed that excess low-affinity ligand
inhibited the phosphorylation as well as degranulation
by the high-affinity ligand. This antagonism results
from a competition for the limiting amount of the 
constitutive initiating kinase. Related receptors that
depend on recruitment of initiating kinases may be
subject to similar regulatory mechanisms.
Key words: IgE receptor, mast cells, membrane
receptors, tyrosine phosphorylation.
OVERVIEW
The IgE/mast cell system is the critical component by
which the abnormal production of IgE in susceptible indi-
viduals elicits the allergic response. Therefore, a fuller
understanding of this could potentially lead to new thera-
peutic approaches to this, the most prevalent of
immunologic diseases. In order to have an experimental
system that can be explored biochemically, it is critical to
select one in which adequate amounts of materials are
available. That is why many researchers have used a
tumor line of mast cells for studies. Subsequent analyses,
by ourselves and others, have confirmed that, with
respect to certain generic aspects of the IgE/mast cell
system we are exploring, the findings from the tumor cells
selected for our work (RBL)1,2 are readily applicable to
normal human mast cells and basophils. However, it is
clear that, for particular pathways, the details may vary
according to both the species and developmental stage
of the cells being investigated.
Many fundamental facts have been established about
the interaction between IgE and mast cells and the mech-
anism by which antigen–IgE complexes stimulate the
cells. The receptor has been molecularly defined with
respect to the type, number and amino acid sequence of
the subunits. Very recently, the first three-dimensional
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picture of the region of the receptor that binds IgE has
been published.3 Hopefully, the region on IgE that binds
to the receptor will also be available at a sufficiently high
resolution before too long. Such information could then
be used to design specific inhibitors of the binding reac-
tion. Some initial favorable clinical results with an anti-IgE
antibody that inhibits binding of IgE without itself trigger-
ing anaphylactic or apparently other mast cell responses4
suggest, therefore, that inhibiting the binding of IgE may
be a practical way of obviating allergic responses.
The early stages of the mast cell response are other
potentially useful targets for interfering with the allergic
response and it is these events on which we have focused.
In this short review, we summarize our current level of
understanding of what is going on.
There is no evidence that the Fce RI receptor itself codes
for an enzymatic activity, but it is now known that the
receptor is associated with a tyrosine kinase and that
phosphorylation of the receptor, on regions referred to as
immunoreceptor tyrosine activation motifs (ITAM),5 and
of other targets is among the earliest consequences of
activation of the receptor.
It is known that one molecule of IgE binds to one mol-
ecule of receptor and vice versa and that the IgE must be
aggregated to initiate a response. The importance of
aggregating the IgE has been clarified by showing that it
is in fact the aggregation of the receptor to which the IgE
is bound that is essential. Indeed, the smallest possible
aggregates, dimers of receptors, have been shown to
generate ‘unit signals’.6 Data from several laboratories
allow the proposal of a specific molecular model for how
the aggregation generates such signals. Such a model is
illustrated in Fig. 1.7,8 The evidence indicates that a small
fraction of receptors are constitutively associated with
weakly bound Lyn kinase. This kinase is unable to phos-
phorylate the receptor with which it is associated.
However, when receptors are aggregated, if the receptors
in the cluster are constitutively associated with Lyn kinase
the latter can transphosphorylate the cytoplasmic domains
of one or more receptors (and associated proteins) in the
aggregate. This phosphorylation leads to the recruitment
of additional (more tightly bound) Lyn kinase and other
cellular proteins, which then propagate the biochemical
cascade. The system is highly dynamic. That is, even
stably clustered receptors appear to be actively phospho-
rylated and dephosphorylated. In the sections that follow,
we describe in greater detail what information we have
about these early events.
INTERACTION OF KINASE WITH RECEPTOR
Several groups have studied the interaction between
Fce RI and Lyn kinase, using a variety of techniques. All of
these studies have revealed a direct interaction between
the kinase and the C-terminal cytoplasmic extension of
the receptor’s b -chain. No interaction has been detected
between Lyn and the N-terminus of the b -chain ( b N) nor
with the cytoplasmic domain of the g -subunits (g C). In our
recent studies, we have used Chinese Hamster Ovary
(CHO) cells, which have small amounts of endogenous
Lyn kinase and had been stably transfected with Fce RI.
Providing the stimulus was sufficiently strong, we
observed aggregation-induced phosphorylation of the
transfected receptors. These cells were then retransfected
with a variety of Lyn kinase constructs: (i) a catalytically
inactive mutant; (ii) a construct consisting of the unique
region of Lyn alone; and (iii) the wild-type kinase. Each of
these types of transfectants yielded informative results.9
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Fig. 1 Model for initial signal
transduction events. Monomeric
receptors ( ) become aggre-
gated when the receptor-bound
antigen-specific IgE binds with a
multivalent antigen. Lyn kinase
( ), constitutively bound to a
small fraction of the receptors, is
then able to phosphorylate
tyrosines on the newly approxi-
mated receptors. The phos-
phorylated receptors recruit addi-
tional lyn kinase, leading to
further phosphorylation and
recruitment of the next down-
stream component, syk kinase
( ).
When compared to the receptors in stimulated control
cells, phosphorylation of the receptors in cells transfected
with the catalytically inactive Lyn was markedly inhibited.
This result indicates that the interaction between Lyn and
the receptor is not dependent on an intact catalytic site on
the kinase. It also suggests that the src-homology domain
2 (SH2) region of Lyn does not play a major role in regu-
lating the level of phosphorylation of the receptor and
may not necessarily be the basis of the recruitment to the
phosphorylated receptors. In any event, the catalytically
inactive Lyn was as effective as the unique domain alone
in inhibiting the interaction between the receptor and the
wild-type endogenous src-family kinase in the CHO cells.
It appears likely that the principal interaction that the
competition experiments are assessing is the constitutive
interaction between Lyn and the receptor. Alternative con-
structs of Lyn could be used to probe further the nature of
this interaction. However, such additional studies could
only provide rather indirect evidence about which struc-
tures in Lyn are important. Rather than pursuing such
intermediate results, what the field really needs is struc-
tural information at the atomic level of resolution. More
detailed analyses must also control for the possibility that
these interactions may be occurring in the context of spe-
cialized membrane domains (see later).
Transfection with the wild-type Lyn enhances the sensi-
tivity of the cells to an aggregating stimulus.9 This is
particularly notable with respect to stimulation with
dimeric IgE. Thus, whereas the cells containing only the
small amount of endogenous Lyn are unresponsive to
dimers, those transfected with wild-type Lyn become
responsive to such a stimulus. The responsiveness of such
transfectants relative to the amount of Lyn they expressed
was determined experimentally and the results have now
been analysed quantitatively The analysis reveals that a
single molecule of kinase per cluster is sufficient to initiate
the response. This is entirely consistent with the molecular
model.
The interpretation that it is the constitutive interaction
that is affected is also consistent with findings reported by
Wilson et al.10 They have observed that a chimeric con-
struct bearing the b c domain fails to become
phosphorylated when transfected into RBL cells, but
inhibits both baseline and aggregation-induced phos-
phorylation of the endogenous Fce RI. This result likely
reflects competition by the transfected b -chain for limiting
amounts of constitutively associated kinase. Thus, this
experiment is, in effect, a mirror image to those we have
described earlier.
Field et al. have provided persuasive evidence that
phosphorylation of the clustered receptors occurs in spe-
cialized microdomains, so-called detergent-insoluble/
glycolipid-enriched domains (DIG).11,12 They have pro-
posed that aggregation of the receptor promotes the
association of the receptors with the DIG and that,
because of the preferential partitioning of Lyn to those
domains, phosphorylation of the receptors by Lyn ensues.
Thus, in their proposal, it is the aggregation-induced
coalescence of the special lipids surrounding the recep-
tors with the lipid rafts enriched in Lyn kinase that initiates
the response, rather than the transphosphorylation mech-
anism. Although we think that taken at its extreme the
lipid domain coalescence model fails to explain a variety
of experimental findings, it is relatively easy to think of
how the two models could be complementary. We would
propose that there is a specific constitutive interaction
between Lyn and the unaggregated receptors and that
Lyn can only phosphorylate immediately neighboring
receptors, but not that with which it is associated.
However, the contemporaneous coalescence of special-
ized lipids around the kinase and clustered receptor
could be an accompanying or, possibly, even a contribut-
ing event.
SITES OF TYROSINE PHOSPHORYLATION
The receptor with high affinity for IgE, Fce RI, belongs to a
family of multichain immuno-recognition receptors
(MIRR).13 Like Fce RI, the cytoplasmic extensions of one or
more of the subunits of each of these receptors contains
one or more ITAM (see earlier), which contain a tyrosine
residue in two canonical Tyr-X-X-Leu/Ile sequences14 and
which are substrates for src-family tyrosine kinases.
The molecular details of the early events triggered by
Fce RI and by related receptors have been explored using
genetically engineered chimeric proteins and mutational
analysis. The findings have varied somewhat, depending
on the system studied, and compared with what is
observed with the intact receptor. Despite the power of
protein engineering, the evidence that is derived from
those approaches is largely circumstantial, particularly
for mutants showing a loss of function. For example, sub-
stituting tyrosine for an alanine or phenylalanine not only
substitutes a residue that can be phosphorylated for one
that cannot, but also substitutes one that has very differ-
ent hydropathicity and hydrogen-bonding properties.
Significant conformational changes in the protein pro-
duced by such a substitution may contribute to, or even
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account for, the functional alterations observed. In addi-
tion, genetic approaches can only indirectly give clues
about the quantitative aspects of any modifications. In
order to complement the mutational studies, we have
examined the phosphorylation of the different subunits in
the native Fce RI directly;15 a kind of analysis that has not
been previously reported for this or any of the other MIRR.
Phosphorylation of the b -subunit
Both canonical tyrosines present in the ITAM of the b -
subunit were phosphorylated, although not to the same
degree. The several-fold greater phosphorylation of
Tyr228 than of Tyr214 was observed both in vivo and in
vitro and to a similar degree. In vivo, the level of phos-
phorylation is the result of a dynamic process of
phosphorylation and dephosphorylation. It may be sup-
posed that in vivo the different levels of phosphorylation
result from a different susceptibility of the two tyrosines to
a phosphatase. However, this would not explain why a
similar differential was observed in vitro in the presence of
the inhibitor vanadate, where all tyrosine phosphatase
activity is eliminated. Alternatively, the differential may
reflect a different accessibility of the two tyrosines to the
receptor-bound kinase(s). If so, then the difference must
be more or less absolute for some of the aggregated
receptors, because the phosphorylation in vitro reached a
plateau value at similar rates for both tyrosines. We have
no additional data to support other explanations.
Recently, various downstream signalling molecules
were shown to interact with a diphosphorylated b ITAM
peptide.16 It is possible that alternative phosphorylations
of the b ITAM tyrosines lead to differential interactions
with such distal components (see, for example, Ortega
et al.17). The results on the b -subunit resemble those
found with the Ig-a chain of the B cell antigen receptor,
where only the canonical tyrosines in the ITAM were phos-
phorylated and to different extents.18 The level of
phosphorylation in Ig-a was minimally affected when one
of the canonical tyrosines was mutated to phenylalanine.
Our data have shown that the non-canonical Tyr224
(which is conserved in the human, mouse and rat b ITAM)
can also become phosphorylated. This tyrosine is at posi-
tion – 4 from the C-terminal canonical tyrosine. Among
the members of the MIRR family, only murine CD3-g has
a non-canonical tyrosine within the ITAM, at position – 3
from the C-terminal canonical tyrosine. In neither
instance is the tyrosine surrounded by a sequence that is
typically found in substrates for src-family kinases.
Phosphorylation of the g -subunit
The phosphorylation of the two canonical tyrosines in the
ITAM of the g -subunit was more equivalent than in the
case of the b -subunit. In vivo, the relative phosphoryla-
tion of Tyr47 (N-terminal peptide) was always larger than
Tyr58 (C-terminal peptide) and the opposite was true in
vitro, but in both cases the ratio was reasonably close to
one. The extent of phosphorylation of the g tyrosines, 
relative to b Tyr218, was two- to three-fold larger in vivo
than in vitro. If one takes into account that about 90% of
the radioactivity in the N-terminal g peptide in vivo is
phosphotyrosine, the average of the ratios in vivo and in
vitro of phosphorylation of the two ITAM tyrosines in g is
roughly one.
Several reports have suggested that it is the phosphory-
lated g -subunit that interacts with Syk kinase. Thus Syk, as
well as its isolated SH2 domains, preferentially binds to
the isolated g - rather than the b -subunit.19 It has also
been shown that peptides containing the g ITAM bind to
and activate Syk kinase.19 Syk and the related ZAP-70
tyrosine kinases contain two consecutive SH2 domains,
whose integrity is required for binding to ITAM and acti-
vation.20 Furthermore, Syk and the related Zap-70 used
by other MIRR family members interact only with bis-
phosphorylated ITAM. Our observations that the
phosphorylation of the two tyrosines in the ITAM of g are
approximately equivalent is consistent with the mech-
anistic model these data imply.
DEPHOSPHORYLATION OF THE RECEPTOR
Although the Lyn kinase associated with the IgE receptor
from resting cells displays tyrosine kinase activity, little or
no phosphorylation of the receptor itself is observed
unless the receptors are aggregated.21 These observa-
tions and those made on the effect of inhibitors of
phosphatases imply that protein tyrosine phosphatase(s)
(PTP) are continuously modulating the resting system. The
studies with inhibitors and other experimental approaches22
have shown that the PTP also continuously act on aggre-
gated receptors. Finally, when individual receptors
dissociate from the aggregate, for example, by addition
of monomeric hapten after stimulation by multivalent
antigen, rapid dephosphorylation of the receptor and of
other cellular proteins is observed.
We recently investigated some of the characteristics of the
PTP responsible for these phenomena. We first developed an
in vitro assay to test the PTP activity in total cell lysate towards
receptors that had been phosphorylated in response to
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aggregation.23 This assay has also been used to localize
candidate PTP to subcellular fractions and to compare the
susceptibility of aggregated and disaggregated receptors.
Finally, we have examined the kinetics of dephosphorylation
for Fce RI and other cellular proteins in vivo, in order to gain
insights about the underlying regulation.
In our assays, the isolated receptors had ‘no’ phos-
phatase associated with them. Swieter et al. have reported
such an association,24 but our results are not necessarily in
conflict. First, Swieter et al. isolated their receptors by pro-
cedures designed to minimize the dissociation of weakly
interacting phosphatase and indeed found that the activity
they measured was relatively easily dissociable. In con-
trast, we deliberately used procedures that would tend 
to dissociate weakly interacting phosphatases, in part
because it is difficult to distinguish between contaminants,
spurious associations and physiologic ones. In addition,
we deliberately wanted to avoid assaying ‘trace’ amounts
of activity. Our assays were conducted at a lower temper-
ature (30°C compared with 37°C) and generally for much
shorter times than those employed by Swieter et al.
Indeed, the activity we are measuring appears in some
instances 100-fold greater than can be estimated from
their paper (see also later).
The studies using cell fractions have suggested that
there are cytosolic phosphatases that in principle may
participate in the dephosphorylation of receptors. How-
ever, much of the activity that we have observed is
localized in the membrane fraction and permeabilized
cells, which have lost many of their cytosolic proteins and
are as efficient in dephosphorylating receptors as intact
cells. Therefore, it appears that membrane-bound phos-
phatases are importantly involved. This finding is, of
course, consistent with a receptor-associated phos-
phatase, such as described by Swieter et al.24 In vivo, a
membrane-bound phosphatase could be vastly more
effective than in vitro assays may reveal, because of prox-
imity and other effects.
That the relevant phosphatase is likely to be membrane
bound raises the question of whether it may be CD45.
Although CD45 has been found to be necessary for acti-
vating a T lymphocyte cell line through the Fce RI with
which it had been transfected,25 the evidence that CD45
is required for the initial IgE-mediated activation of mast
cells is contradictory.26–28 There is also another consider-
ation. We have already referred to the experiments of
Field et al., which suggest an important, possibly critical,
role for specialized membrane domains.11,12 One could
propose a model in which such domains are deficient 
in phosphatases. This paucity, coupled with an enrich-
ment in kinase(s), could promote the phosphorylation of
the aggregated receptors that become associated with
these regions. Indeed, CD45 is thought to be excluded
from these specialized domains29 and there are experi-
mental data that suggest that this exclusion may be
involved in regulating the activation of the kinase Lck in T
lymphocytes.30
We have tested the possibility that in RBL cells, the spe-
cialized membrane regions may be deficient in PTP
necessary to dephosphorylate Fce RI, but found no evi-
dence for such a deficiency.23 We aggregated receptors
under conditions shown to promote the association of the
receptors with such domains and then blocked continued
kinase action with ethylenediaminetetraacetic acid
(EDTA). There was, nevertheless, prompt dephosphoryla-
tion of the receptors. These observations parallel our
previous findings on the dynamic phosphorylation/
dephosphorylation to which smaller aggregates of the
receptor are subject.22
We have also examined this latter aspect quantitatively
in vitro, by comparing the susceptibility of aggregated
versus disaggregated receptors to dephosphorylation by
PTP. The results have shown that aggregation did not
protect the phosphorylated tyrosines from hydrolysis.
These results lead us to a simple kinetic scheme consis-
tent with our proposed molecular model (Fig. 2).23
Earlier data has shown that k– 22 is substantial and
effectively overwhelms k22. The new data has indicated
that k–12 approximately equals k–22. Possibly, by promot-
ing interactions with the cytoskeleton, phosphorylation
stabilizes the aggregated state of receptors, thereby
enhancing the ratio kf/kr by decreasing kr. It follows that
the concentration of the aggregated phosphorylated
species, which appears to be the critical component that
initiates the cascade of events, will be independently
determined by the ratio kf/kr for both the unphosphory-
lated and the phosphorylated receptors and by k12/k–12.
Thus, the cell maintains a constant brake on this system
through the constitutive action of phosphatases and
aggregation moves the system, principally by enhancing
the effectiveness of kinases.
QUANTITATIVE ANALYSIS
Competition for limited kinase
Under certain conditions of stimulation, phosphorylation
of the receptors reaches a plateau well before aggregation
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of additional receptors has ceased.31 We have eliminated
several obvious explanations, such as that phosphatase is
activated (earlier), and have hypothesized that aggre-
gated receptors are competing for limited amounts of the
initiating src-family kinase.
To test this hypothesis, a proportion of receptors was
stably aggregated by dimers of rat IgE (weak stimulus)
prior to the aggregation by antigen of other receptors on
the same cells bearing anti-dinitrophenyl (anti-DNP)
mouse IgE (strong stimulus). In some instances, the latter
aggregates were dissociated a few minutes later by
adding monovalent hapten. The receptors were individu-
ally analysed by immunoprecipitating them with species-
specific anti-IgE.32
We observed that receptors aggregated by a strong
stimulus became phosphorylated at the same time as
those receptors that were stably aggregated by dimeric
IgE were becoming dephosphorylated. Therefore, ini-
tially, the dimers become phosphorylated by virtue of their
constitutively associated Lyn kinase. By the addition of
antigen, a competing reaction was promoted and when
these new aggregates were in excess, they monopolized
the limited Lyn to which the Fce RI have access.
The addition of hapten disaggregated the competing
species and their rapid dephosphorylation restored the
pool of Lyn to its original size, so that the stable dimers
regained access to Lyn and were rephosphorylated. The
rephosphorylation of the pre-existing oligomers is consis-
tent with our previous results that demonstrated that at
least modest-sized aggregates of Fce RI are subject to
repeated cycles of phosphorylation, dephosphorylation
and rephosphorylation over considerable periods of
time.22
Effects of affinity
Ligands binding to cell-surface receptors typically stimu-
late elaborate biochemical cascades. If the initiating
interaction(s) must be preserved during the subsequent
steps, then ligands with lower affinity, which generally
means those forming complexes with shorter lifetimes,
will be less likely to stimulate responses that go to com-
pletion. This process has been dubbed ‘kinetic
proofreading’33 and has been creatively applied to sig-
nalling by the antigen receptors of T cells and possibly to
account for the action of variant peptides that can act as
partial agonists or antagonists.34
We have examined the kinetic proofreading formula-
tion in the context of Fce RI and explored whether ligands
of differing affinity can act as mutual antagonists under
conditions where simple displacement cannot occur.35
We loaded cells with IgE and monitored responses to
high- or low-affinity ligands. On addition of the high-
affinity DNP-antigen, tyrosines on both the b - and
g -subunits of Fce RI were phosphorylated with compara-
ble kinetics. The phosphorylation of the kinase Syk and
the adaptor protein Nck reached a maximum shortly
afterwards and the phosphorylation of the extracellular
signal-regulated (ERK)2 kinase even later. Higher and
lower doses of the antigen correspondingly accelerated
or slowed the kinetics of phosphorylation, but the order in
which the proteins were modified was unaltered.
The anti-DNP IgE binds the 2-nitrophenyl (2NP) moiety
with a relative intrinsic affinity less than 0.001 of that for
DNP. At comparable doses, the 2NP hapten-conjugate
induced less vigorous phosphorylation of the Fce RI than
the DNP antigen, but this could be compensated for by
using somewhat higher doses. The striking finding was
that, per unit phosphorylation of the receptor, the low-
affinity ligand was progressively less effective in activating
‘downstream’ components. Thus, even when the phos-
phorylation of the receptor stimulated by 2NP was more
than two-fold higher, the maximum phosphorylation of
Syk was less than one-third of that achieved by the high-
affinity ligand and for ERK2, only one-tenth as much. The
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Fig. 2 Kinetic scheme for phosphorylation of receptors after
aggregation. R, Fce RI with bound monomeric IgE. The binding
of multivalent antigen to the IgE leads to the formation of
aggregated receptors, Rn, with a forward rate constant of kf
and a dissociation rate constant of kr. The size of the arrows
depicting the phosphorylation and dephosphorylation of the
aggregated and monomeric receptors reflects the experimental
finding that phosphorylation is governed by the fact that k12 >
k22 and not because k–12 differs from k–22. P, phosphotyrosine.
weakly bound 2NP ligand also stimulated release of
hexosaminidase very poorly. These findings are consistent
with a kinetic proofreading regimen.
Variant peptides can antagonize the stimulation of T
lymphocytes induced by wild-type peptides under non-
displacing conditions. We have examined whether a
similar effect is observed in responses mediated by
Fce RI.35 Cells were loaded with a mixture of two mono-
clonal mouse IgE, one having a high affinity for DNP and
the other having a high affinity for the non-cross-reacting
dansyl moiety (DNS). The cells were then exposed either to
the DNS-protein conjugate, to the low-affinity 2NP con-
jugate or to both simultaneously and immunoprecipitates
of several proteins were assayed for phosphotyrosine.
In response to the dose of the DNS conjugate used, the
phosphorylation of Fce RI was modest but sufficient to
stimulate phosphorylation of the three downstream com-
ponents examined: Syk, Pyk2 and ERK2. Pyk2, a member
of the family of ‘focal adhesion’ kinases is phosphory-
lated subsequent to the activation of Syk.36 When the cells
were stimulated with only the low-affinity 2NP ligand, the
receptors were phosphorylated but phosphorylation of
the downstream components was progressively dimin-
ished. If the cells were stimulated with the mixture of
non-cross-reacting ligands, the phosphotyrosine in the
total receptor subunits was undiminished, phosphoryl-
ation of Syk and Pyk2 was minimally reduced, but
phosphorylation of ERK2 was substantially decreased.
Secretion of hexosaminidase was also measured.
Increasing doses of the low-affinity ligand progressively
inhibited release. We eliminated the possibility that the
2NP was simply ‘toxic’ and showed that in order to man-
ifest its inhibitory capacity, the low-affinity ligand had to
be bound to the same cells as the high-affinity ligand.
Further experiments have shown that the weakly clus-
tered receptors act like the ‘dog in the manger’: despite
their inability to use Lyn productively, they impede the
access of the more stable clusters to the kinase. In princi-
ple, the molecular mechanism we have uncovered can
relate to other receptors that require recruitment of an
extrinsic component in limited supply and that are subject
to a kinetic proofreading regimen. In the immune system,
the family of multichain immune recognition receptors
and the cytokine receptors are obvious candidates.
CLOSING REMARKS
Considerable headway is being made in defining, in mol-
ecular terms, the early events associated with the binding
of IgE to the high-affinity receptor and the consequences
of multivalent antigen binding to the cell-bound IgE. The
molecular events are highly analogous to the initiation of
cellular responses by many other cell-surface receptors
that use clustering of the receptors as a fundamental
mechanism. However, much remains to be uncovered. At
the structural level we are only at the beginning, both with
respect to the receptor and to downstream components.
Although for the latter we have by now quite a few X-ray
structures, there is increasing evidence that signalling is
not occurring, either free in solution or even simply
through sequential interactions between isolated compo-
nents. Rather, there is mounting evidence that signalling
occurs in the context of multicomponent macromolecular
complexes. The fact that, in the case of signalling path-
ways, these ‘protein machines’ may be metastable
structures evolving over time, vastly complicates their
analysis.
We are only beginning to discern the true complexity
of the systems we are exploring. Consider that a dimer
of Fc e RI, which contains 12 canonical and two non-
canonical tyrosines in the ITAM that may or may not be
phosphorylated, has potentially 214 (> 17 000) unique
states and Syk kinase, with six phosphorylatable
tyrosines,37 has 64 potential states. Determining which
of these are truly functionally significant is a major
undertaking. Although computers can provide a suitable
substitute for our obviously inadequate personal
memory banks to store the details of the elaborate path-
ways, they will have to be provided with new software so
that the massive amount of new data can be usefully
integrated. One way is illustrated by the work of Bhalla
and Iyengar, who have shown how data on individual
pathways that are known to be linked can be analysed.38
They have come up with some striking examples of how
such networked pathways may lead to a variety of ‘emer-
gent’ properties; that is, properties that were not
predictable from behavior of the individual pathways.
This is the exciting prospect before us as we move into
the brave new ‘era of pathway quantitation’.39
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